FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/069987 [Registered on: 04/07/2024] Trial Registered Prospectively
Last Modified On: 01/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   a clinical trial to study effect of repetitive transcranial magnetic stimulation in gait and behavioral changes patients with progressive supranuclear gaze palsy 
Scientific Title of Study   Effect of rTMS on motor and nonmotor symptoms of progressive surpanuclear plasy : Randomised controlled study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Deepika Joshi 
Designation  Professor  
Affiliation  IMS, BHU, varanasi 
Address  Department of neurology, IMS, BHU,Varanasi 221005

Varanasi
UTTAR PRADESH
221005
India 
Phone  9918978666  
Fax    
Email  drdeepikajoshi73@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Janki Makani 
Designation  senior resident  
Affiliation  IMS, BHU, varanasi 
Address  sir sunderlal hospital, IMS, BHU, varanasi, uttar pradesh
same
Varanasi
UTTAR PRADESH
221005
India 
Phone  9099889038  
Fax    
Email  jnkmakani@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Deepika Joshi 
Designation  Professor  
Affiliation  IMS, BHU, varanasi 
Address  Department of neurology, IMS, BHU,Varanasi 221005

Varanasi
UTTAR PRADESH
221005
India 
Phone  9918978666  
Fax    
Email  drdeepikajoshi73@gmail.com  
 
Source of Monetary or Material Support  
Department of neurology,Sir Sunderlal Hospital, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh,India Pincode 221005 
 
Primary Sponsor  
Name  dr deepika Joshi 
Address  Department of Neurology, Sir Sunderlal Hospital, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India pincode 221005  
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
drDeepika Joshi  Sir Sunderlal Hospital, Institute of Medical Sciences, Banaras Hindu Univresity  Department of Neurology
Varanasi
UTTAR PRADESH 
9918978666

drdeepikajoshi73@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethics Committee, IMS, Banaras Hindu University  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G00-G99||Diseases of the nervous system, (2) ICD-10 Condition: G231||Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski],  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  repetitive transcranial magnetic stimulation( placebo)  2 sets of 5 daily sessions 1 month apart for 240 seconds of sham protocol mimicking intervention 
Intervention  repetitive transcranial nerve stimulation  2 sets of 5 daily sessions 1 month apart with coil positioned 3 cm lateral to inion , 1 cm inferior to lateral cerebellum. 20 trains of 10 bursts with 8 second interval total 600 pulses in 240 seconds. 3 50 hz pulses repeated at the rate of 5 hz. 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  85.00 Year(s)
Gender  Both 
Details  probable or possible PSP defined by MDS criteria
ability to stand unassisted for 30 seconds and ability to walk independently with walker
MMSE 18 or more
on stable treatment of anticholinergic, dopaminergic , serotonergic sedative or NMDA receptor antagonist 
 
ExclusionCriteria 
Details  history of cerebellar ataxia, subdural hematoma, space occupying lesion, hydrocephalus
prior vestibular disease
sensory deficit in feet
epilepsy and psychotic disorder active intake of antiseizure medication
pregnancy
presence of electrically, magnetically active implants or metal exposures that preclude use of rTMS 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
to study efficacy in motor and nonmotor symptoms after cerebellar rTMS in progressive supranuclear palsy compared to sham procedure
with parameters like
PSP rating scale
MDS non motor rating scale
UPDRS part III
PSP CDS
MOCA
FAB 
patient will be assessed at the time of enrollment, at 1 month and at 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
to look for non motor and behavioral changes in patients with PSP  patient will be assessed at the time of enrollment, at 1 month and at 6 months 
 
Target Sample Size   Total Sample Size="86"
Sample Size from India="86" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   11/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   this is a randomized placebo controlled trial to assess the efficacy of repetitive transcranial magnetic stimuli in motor and non motor symptoms of progressive supranuclear palsy. this trial is conducted to assess various parameters and improvement in gait after the intervention. 
Close